OrbiMed Capital GP VI LLC
- SEC CIK
- 0001682115
In the past year, 1 open-market purchase filing worth $5.00M and 1 sale filing worth $674.8K.
Current role at each company
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Apr 23, 2026
- IMA ImageneBio, Inc.Directoras of Apr 16, 2026
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- TSBX Turnstone Biologics Corp.Directoras of Aug 12, 2025
- NPCE NeuroPace Inc10% Owneras of May 16, 2025
Show 9 more companies
- CMPX Compass Therapeutics, Inc.Director, 10% Owneras of Apr 11, 2025
- EWTX Edgewise Therapeutics, Inc.Director, 10% Owneras of Apr 4, 2025
- IRON Disc Medicine, Inc.Directoras of Mar 26, 2025
- SPRY ARS Pharmaceuticals, Inc.Directoras of Aug 28, 2024
- SCPH scPharmaceuticals Inc.10% Owneras of Aug 15, 2024
- ALPN Alpine Immune Sciences, Inc.Directoras of May 20, 2024
- VRNA Verona Pharma plcDirectoras of May 15, 2023
- SWTX SpringWorks Therapeutics, Inc.10% Owneras of Sep 14, 2022
- ETNB 89bio, Inc.10% Owneras of Jan 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.00M
- 1 filing
- Sold
- $674.8K
- 1 filing
- Net
- +$4.33M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Capital GP VI LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRLD Prelude Therapeutics Inc
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 (view filing)6:48 PM ET | Apr 21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +2.82M | $4.44 | +$12.5M | New position1.13M after | 2 lotsDuplicate filing |
| May 24, 2023 (view filing)5:09 PM ET | May 22 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +869.6K | $5.75 | +$5.00M | +9.4%10.1M after | Duplicate filing |
IMA ImageneBio, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 (view filing)7:23 PM ET | Apr 14 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +721.3K | – | – | –384.7K after | Derivative2 lotsDuplicate filing |
| Jun 24, 2022 (view filing)5:39 PM ET | Jun 22-24 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | −252.2K | $4.47 | −$1.13M | −10.7%2.10M after | 4 lotsDuplicate filing |
ACET Adicet Bio, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 (view filing)5:38 PM ET | Apr 7-8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | SSale | −104.7K | $6.45 | −$674.8K | −100.0%0 after | 4 lots |
| Oct 10, 2025 (view filing)8:06 PM ET | Oct 8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | PPurchase | +5.00M | $1.00 | +$5.00M | New position4.49M after | 2 lots |
| Jan 26, 2024 (view filing)7:14 PM ET | Jan 25 | 1 day | OrbiMed Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +3.13M | $2.40 | +$7.50M | New position1.26M after | 3 lotsDuplicate filing |
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |
NPCE NeuroPace Inc
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 (view filing)5:26 PM ET | May 14 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −168.1K | $15.85 | −$2.67M | −4.9%3.24M after | 2 lots |
| May 3, 2024 (view filing)5:16 PM ET | May 1-3 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −29.2K | $14.02 | −$409.4K | −0.9%3.41M after | 3 lots |
| Apr 26, 2024 (view filing)5:01 PM ET | Apr 24 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −1.78K | $14.06 | −$25.0K | −0.1%3.44M after | |
| Apr 23, 2024 (view filing)6:38 PM ET | Apr 19-23 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −64.7K | $14.12 | −$913.1K | −1.8%3.44M after | 3 lots |
| Apr 18, 2024 (view filing)5:10 PM ET | Apr 16-18 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −17.0K | $14.02 | −$238.2K | −0.5%3.50M after | 3 lots |
| Apr 15, 2024 (view filing)5:25 PM ET | Apr 11-12 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −485.0K | $14.49 | −$7.03M | −12.1%3.52M after | 2 lots |
| Oct 4, 2023 (view filing)5:36 PM ET | Oct 2-3 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −8.31K | $9.07 | −$75.4K | −0.2%4.00M after | 2 lots |
CMPX Compass Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 (view filing)7:24 PM ET | Apr 9 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | SSale | −3.57M | $1.59 | −$5.68M | −100.0%0 after | Duplicate filing |
EWTX Edgewise Therapeutics, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 (view filing)7:33 PM ET | Apr 3 | 1 day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +496.8K | $20.13 | +$10.0M | New position443.8K after | 2 lotsDuplicate filing |
| Jan 25, 2024 (view filing)4:28 PM ET | Jan 23 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +454.5K | $11.00 | +$5.00M | +3.3%14.4M after | Duplicate filing |
| Sep 16, 2022 (view filing)4:31 PM ET | Sep 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +484.5K | $10.32 | +$5.00M | +3.6%14.0M after | Duplicate filing |
| May 20, 2022 (view filing)4:38 PM ET | May 18 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +138.0K | $7.21 | +$995.0K | +1.0%13.5M after | Duplicate filing |
IRON Disc Medicine, Inc.
Director8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 (view filing)7:00 PM ET | Mar 24 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −5.74K | $54.11 | −$310.5K | −3.0%186.5K after | 3 lotsDuplicate filing |
| Mar 21, 2025 (view filing)8:00 PM ET | Mar 19-21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −52.4K | $54.02 | −$2.83M | −21.9%187.3K after | 9 lotsDuplicate filing |
| Mar 12, 2025 (view filing)9:34 PM ET | Mar 10-12 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −312.4K | $54.31 | −$17.0M | −61.7%194.2K after | 15 lotsDuplicate filing |
| Jun 20, 2024 (view filing)5:19 PM ET | Jun 17 | 3 days | OrbiMed Advisors LLC and 3 othersDirector | PPurchase | +83.3K | $36.00 | +$3.00M | +54.8%235.4K after | 3 lotsDuplicate filing |
| Dec 20, 2023 (view filing)6:28 PM ET | Dec 18 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −1.72K | $59.24 | −$102.1K | −100.0%0 after | Duplicate filing |
| Dec 15, 2023 (view filing)6:04 PM ET | Dec 14 | 1 day | OrbiMed Advisors LLC and 3 othersDirector | SSale | −433.2K | $56.75 | −$24.6M | −65.9%224.4K after | 3 lotsDuplicate filing |
| Dec 14, 2023 (view filing)5:44 PM ET | Dec 12-14 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −134.2K | $58.88 | −$7.90M | −15.6%727.8K after | 8 lotsDuplicate filing |
| Feb 17, 2023 (view filing)4:43 PM ET | Feb 15 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +108.7K | $23.00 | +$2.50M | +57.1%299.2K after | 3 lotsDuplicate filing |
SPRY ARS Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 (view filing)4:26 PM ET | Aug 26 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −83.7K | $13.00 | −$1.09M | −100.0%0 after | Duplicate filing |
| Aug 23, 2024 (view filing)6:38 PM ET | Aug 21-23 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −868.7K | $13.24 | −$11.5M | −91.2%83.7K after | 4 lotsDuplicate filing |
| Aug 31, 2023 (view filing)5:26 PM ET | Aug 29 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +500.0K | $6.20 | +$3.10M | +6.6%8.02M after | Duplicate filing |
SCPH scPharmaceuticals Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing)4:51 PM ET | Aug 13 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | PPurchase | +500.0K | $4.00 | +$2.00M | New position252.9K after | 2 lots |
| Nov 29, 2022 (view filing)4:36 PM ET | Nov 25 | 4 days | OrbiMed Advisors LLC and 2 others10% Owner | PPurchase | +762.4K | $5.25 | +$4.00M | +16.7%5.33M after |
ALPN Alpine Immune Sciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 (view filing)4:18 PM ET | Dec 27-28 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −1.55M | $18.54 | −$28.7M | −85.4%264.3K after | 6 lotsDuplicate filing |
| Sep 21, 2021 (view filing)6:42 PM ET | Sep 17 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.01M | $9.40 | +$9.50M | New position425.5K after | 2 lotsDuplicate filing |
TSBX Turnstone Biologics Corp.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2023 (view filing)4:38 PM ET | Jul 20 | 4 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +416.7K | $12.00 | +$5.00M | +15.5%3.10M after | Duplicate filing |
VRNA Verona Pharma plc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2023 (view filing)6:07 PM ET | May 11-15 | 4 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −482.9K | $20.58 | −$9.94M | −11.3%3.78M after | 4 lotsDuplicate filing |
| Dec 27, 2022 (view filing)5:38 PM ET | Dec 22-23 | 5 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −6.14M | $22.15 | −$136.0M | −15.3%34.1M after | 5 lotsDuplicate filing |
SWTX SpringWorks Therapeutics, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 (view filing)4:24 PM ET | Sep 12 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −153.9K | $31.96 | −$4.92M | −2.7%5.60M after | 2 lots |
| Aug 10, 2022 (view filing)4:22 PM ET | Aug 8-9 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −274.6K | $38.11 | −$10.5M | −4.6%5.75M after | 2 lots |
| Jul 6, 2021 (view filing)4:42 PM ET | Jul 1 | 5 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −16.0K | $85.01 | −$1.36M | −0.3%6.03M after |
ETNB 89bio, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2022 (view filing)5:22 PM ET | Jan 25-26 | 2 days | OrbiMed Advisors LLC and 3 others10% Owner | SSale | −70.6K | $8.39 | −$592.4K | −3.7%1.83M after | 4 lots |